HIGHLIGHTS
- who: Qing-Yang Wu from the State Key Laboratory of Bioreactor, Shanghai Collaborative Innovation Centre for Biomanufacturing, College of Biotechnology, East China University of Science Technology, Shanghai, People’s Republic have published the Article: Construction of an Escherichia coli cell factory to synthesize taxadien-5α-ol, the key precursor of anti-cancer drug paclitaxel, in the Journal: (JOURNAL)
- what: The authors report a recombinant strain constructed with a heterologous pathway a synthase from yew a cytochrome P450-mediated oxygenation system for the de novo production of taxadien-5α-ol the first product of the multi . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.